📊 DLB Key Takeaways
Is Dolby Laboratories, Inc. (DLB) a Good Investment?
Dolby Laboratories demonstrates exceptional financial health with industry-leading profitability margins (87.5% gross, 17.9% operating) and strong liquidity (3.17x current ratio). The company generates substantial free cash flow ($50.2M) with minimal leverage, supported by a fortress balance sheet with $643.8M cash and zero long-term debt.
Dolby Laboratories shows excellent underlying business quality through very high gross margins, solid free cash flow generation, and an exceptionally strong balance sheet with substantial cash and no long-term debt. However, the reported revenue surge did not translate into meaningful earnings growth, while ROE and ROA remain modest, suggesting growth quality and capital efficiency are less compelling than the margin profile alone would imply.
Why Buy Dolby Laboratories, Inc. Stock? DLB Key Strengths
- Exceptional gross margin of 87.5% indicating strong pricing power and operational efficiency
- Fortress balance sheet with $643.8M cash, zero long-term debt, and 0.00x debt-to-equity ratio
- Strong free cash flow generation of $50.2M (14.5% FCF margin) with minimal capex requirements
- Excellent liquidity metrics (3.17x current ratio, 3.10x quick ratio) providing substantial financial flexibility
- High interest coverage ratio of 386.1x reflecting minimal financial risk
- Substantial insider activity with 13 Form 4 filings in last 90 days
- Exceptionally high gross margin of 87.5% indicates strong IP-based economics and pricing power
- Balance sheet is very conservative with $643.85M in cash, no long-term debt, and strong liquidity above 3.0x
- Business remains cash generative with positive operating cash flow and free cash flow, supported by minimal capital expenditure needs
DLB Stock Risks: Dolby Laboratories, Inc. Investment Risks
- Revenue spike of 8674.3% YoY appears anomalous and warrants investigation into one-time items or accounting changes affecting comparability
- Low returns on equity (2.1%) and assets (1.7%) despite strong margins suggest significant underutilized capital or asset base inefficiency
- Net income essentially flat YoY (-0.6%) despite massive revenue growth indicates margin compression or significant non-operating headwinds
- Diluted EPS declined 2.6% YoY despite revenue growth, suggesting share dilution or operating deleverage
- Patent licensing business model may face regulatory or competitive pressures affecting revenue sustainability
- Revenue growth quality is questionable because revenue rose sharply while net income and EPS were flat to down
- Low ROE of 2.1% and ROA of 1.7% suggest weak capital efficiency relative to the size of the asset and equity base
- Operating margin of 17.9% and net margin of 15.4% are healthy but not improving enough to confirm strong earnings leverage from top-line growth
Key Metrics to Watch
- Operating cash flow sustainability and working capital trends to validate revenue growth quality
- Gross margin trends to confirm whether the 87.5% margin is sustainable or inflated by one-time items
- Return on equity and asset efficiency metrics to understand capital deployment effectiveness
- Revenue composition and licensing revenue recognition patterns given the unusual YoY growth
- Net income and EPS growth relative to revenue growth
- Free cash flow margin and return on equity
Dolby Laboratories, Inc. (DLB) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 3.17x current ratio provides a solid financial cushion.
DLB Profit Margin, ROE & Profitability Analysis
DLB vs Market Sector: How Dolby Laboratories, Inc. Compares
How Dolby Laboratories, Inc. compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Dolby Laboratories, Inc. Stock Overvalued? DLB Valuation Analysis 2026
Based on fundamental analysis, Dolby Laboratories, Inc. has mixed fundamental signals relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Dolby Laboratories, Inc. Balance Sheet: DLB Debt, Cash & Liquidity
DLB Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Dolby Laboratories, Inc.'s revenue has shown modest growth of 5% over the 5-year period. The most recent EPS of $2.05 reflects profitable operations.
DLB Revenue Growth, EPS Growth & YoY Performance
DLB Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $346.7M | $53.3M | $0.55 |
| Q3 2025 | $288.8M | $38.4M | $0.40 |
| Q2 2025 | $364.5M | $91.8M | $0.94 |
| Q1 2025 | $315.6M | $67.0M | $0.69 |
| Q3 2024 | $288.8M | $16.4M | $0.17 |
| Q2 2024 | $364.5M | $95.7M | $0.98 |
| Q1 2024 | $315.6M | $67.0M | $0.69 |
| Q3 2023 | $289.6M | $16.4M | $0.17 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Dolby Laboratories, Inc. Dividends, Buybacks & Capital Allocation
DLB SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Dolby Laboratories, Inc. (CIK: 0001308547)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DLB
What is the AI rating for DLB?
Dolby Laboratories, Inc. (DLB) has a Combined AI Rating of BUY from Claude (STRONG BUY) and ChatGPT (HOLD) with 80% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are DLB's key strengths?
Claude: Exceptional gross margin of 87.5% indicating strong pricing power and operational efficiency. Fortress balance sheet with $643.8M cash, zero long-term debt, and 0.00x debt-to-equity ratio. ChatGPT: Exceptionally high gross margin of 87.5% indicates strong IP-based economics and pricing power. Balance sheet is very conservative with $643.85M in cash, no long-term debt, and strong liquidity above 3.0x.
What are the risks of investing in DLB?
Claude: Revenue spike of 8674.3% YoY appears anomalous and warrants investigation into one-time items or accounting changes affecting comparability. Low returns on equity (2.1%) and assets (1.7%) despite strong margins suggest significant underutilized capital or asset base inefficiency. ChatGPT: Revenue growth quality is questionable because revenue rose sharply while net income and EPS were flat to down. Low ROE of 2.1% and ROA of 1.7% suggest weak capital efficiency relative to the size of the asset and equity base.
What is DLB's revenue and growth?
Dolby Laboratories, Inc. reported revenue of $346.7M.
Does DLB pay dividends?
Dolby Laboratories, Inc. pays dividends, with $34.3M distributed to shareholders in the trailing twelve months.
Where can I find DLB SEC filings?
Official SEC filings for Dolby Laboratories, Inc. (CIK: 0001308547) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DLB's EPS?
Dolby Laboratories, Inc. has a diluted EPS of $0.55.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is DLB a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Dolby Laboratories, Inc. has a BUY rating with 80% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is DLB stock overvalued or undervalued?
Valuation metrics for DLB: ROE of 2.1% (sector avg: 15%), net margin of 15.4% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy DLB stock in 2026?
Our dual AI analysis gives Dolby Laboratories, Inc. a combined BUY rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is DLB's free cash flow?
Dolby Laboratories, Inc.'s operating cash flow is $54.8M, with capital expenditures of $4.6M. FCF margin is 14.5%.
How does DLB compare to other Market stocks?
Vs Default sector averages: Net margin 15.4% (avg: 12%), ROE 2.1% (avg: 15%), current ratio 3.17 (avg: 1.8).